5-HT6 receptors:: a novel target for cognitive enhancement

被引:200
作者
Mitchell, ES [1 ]
Neumaier, JF [1 ]
机构
[1] Univ Washington, Harborview Med Ctr, Seattle, WA 98104 USA
关键词
D O I
10.1016/j.pharmthera.2005.05.001
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Over the past decade, there has been increasing interest in the role of serotonin 6 (5-HT6) receptors in higher cognitive processes such as memory. Polymorphisms of the 5-HT6 receptor have been implicated in syndromes that affect cognition, such as schizophrenia and dementia. Manipulation of 5-HT6 receptor activity alters the transmission of several neurotransmitters important in memory: acetylcholine and glutamate, as well as dopamine, a-aminobutyric acid (GABA), epinephrine (E), and norepinephrine (NE). Several 5-HT6 antagonists have been developed, advancing the understanding of the relationship between 5-HT6 blockade and memory consolidation in diverse learning paradigms, There is also evidence that 5-HT6 receptor activity affects anxiety behaviors and may be involved in the pathophysiology of schizophrenia. Several clinically useful atypical antipsychotics and antidepressants have 5-HT6 affinity, but recently developed selective 5-HT6 receptor antagonists may present attractive, new therapeutic options for several types of disease states. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:320 / 333
页数:14
相关论文
共 90 条
[1]   5-hydroxytryptamine 6 receptor (5-HT6) receptor and apolipoprotein E (ApoE) polymorphisms in patients with Alzheimer's disease in the Basque Country [J].
Alvarez-Alvareza, M ;
Galdos, L ;
Fernández-Martínez, M ;
Gómez-Busto, F ;
García-Centeno, V ;
Arias-Arias, C ;
Sánchez-Salazar, C ;
Rodríguez-Martínez, AB ;
Zarranz, JJ ;
de Pancorbo, MM .
NEUROSCIENCE LETTERS, 2003, 339 (01) :85-87
[2]  
Barden N, 2004, J PSYCHIATR NEUROSCI, V29, P185
[3]   Acute amygdalar activation induces an upregulation of multiple monoamine G protein coupled pathways in rat hippocampus [J].
Benes, FM ;
Burke, RE ;
Walsh, J ;
Berretta, S ;
Matzilevich, D ;
Minns, M ;
Konradi, C .
MOLECULAR PSYCHIATRY, 2004, 9 (10) :932-945
[4]   Investigation of stretching behaviour induced by the selective 5-HT6 receptor antagonist, Ro 04-6790, in rats [J].
Bentley, JC ;
Bourson, A ;
Boess, FG ;
Fone, KCF ;
Marsden, CA ;
Petit, N ;
Sleight, AJ .
BRITISH JOURNAL OF PHARMACOLOGY, 1999, 126 (07) :1537-1542
[5]   The 5-hydroxytryptamine, receptor-selective radioligand [3H]Ro 63-0563 labels 5-hydroxytryptamine receptor binding sites in rat and porcine striatum [J].
Boess, FG ;
Riemer, C ;
Bös, M ;
Bentley, J ;
Bourson, A ;
Sleight, AJ .
MOLECULAR PHARMACOLOGY, 1998, 54 (03) :577-583
[6]  
BONASERA SJ, 2001, AGS ANN M
[7]   5-HT6 receptor antagonists:: lead optimisation and biological evaluation of N-aryl and N-heteroaryl 4-amino-benzene sulfonamides [J].
Bös, M ;
Sleight, AJ ;
Godel, T ;
Martin, JR ;
Riemer, C ;
Stadler, H .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2001, 36 (02) :165-178
[8]  
BOURSON A, 1995, J PHARMACOL EXP THER, V274, P173
[9]   5-HT6 receptors as emerging targets for drug discovery [J].
Branchek, TA ;
Blackburn, TP .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2000, 40 :319-334
[10]   5-chloro-N-(4-methoxy-3-piperazin-1-yl-phenyl)-3-methyl-2-benzothiophenesulfonamide (SB-271046):: A potent, selective, and orally bioavailable 5-HT6 receptor antagonist [J].
Bromidge, SM ;
Brown, AM ;
Clarke, SE ;
Dodgson, K ;
Gager, T ;
Grassam, HL ;
Jeffrey, PM ;
Joiner, GF ;
King, FD ;
Middlemiss, DN ;
Moss, SF ;
Newman, H ;
Riley, G ;
Routledge, C ;
Wyman, P .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (02) :202-205